4//SEC Filing
Giffin Brett A. 4
Accession 0000899243-23-007727
CIK 0001492674other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:00 PM ET
Size
8.7 KB
Accession
0000899243-23-007727
Insider Transaction Report
Form 4
Giffin Brett A.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-02-22$0.65/sh−537$349→ 841 total - Exercise/Conversion
Common Stock
2023-02-20+1,333→ 1,378 total - Exercise/Conversion
Restricted Stock Units
2023-02-20−1,333→ 2,667 total→ Common Stock (1,333 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on November 10, 2021.
- [F3]On February 20, 2022 the reporting person was granted 4,000 RSU's that vest in three equal annual installments commencing on February 20, 2023
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001892921
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:00 PM ET
- Size
- 8.7 KB